Study paves way for personalized medicine based on patient’s own genetic ‘baggageJune 20th, 2008 - 5:02 pm ICT by ANI
Washington, June 20 (ANI): A new study has shown how minor genetic differences between individuals alter the way a common drug affects the body paving the way for personalized medicine that is based not only on symptoms but also on the patient’s own genetic ‘baggage.
The study was conducted by Dr Rima Rozen of the Research Institute of the McGill University Health Centre (RI MUHC) at the Montreal Children’s Hospital and McGill University.
For the study, Rozen measured the impact of Methotrexate - a drug that inhibits the metabolism of folate - on mice with an altered MTHFR gene, which is a gene crucial for folate metabolism.
She found that after treatment with Methotrexate, mice with the altered gene had approximately 20 per cent less hemoglobin and red blood cells than their counterparts with non-altered genes.
The altered mice also showed increased susceptibility to liver and kidney damage following treatment.
“We know that these results are applicable to humans because a parallel mutation in the human MTHFR gene affects human folate metabolism similarly. The results demonstrate that medication affects subjects differently according to individual genetic traits. And tests exist to detect this mutation,” Dr. Rozen said.
Genetic testing would allow physicians the modify treatment based on each patient’s personal genetic makeup, limiting potential side effects.
“This is a first step towards personalized medicine that is based not only on symptoms but also on the patient’s own genetic ‘baggage.’ This trend definitely represents the medicine of the future,” Rozen said.
The study is published in the journal Pharmacogenetics and Genomics. (ANI)
- Gene linked with vitamin B12 deficiency found - Aug 27, 2012
- New method can help identify genetic disease in record time - Jun 11, 2010
- Study solves 35-yr-old medical mystery using genetics - Jan 29, 2011
- Gene that can influence a person's risk for developing epilepsy identified - Apr 05, 2011
- Mouse genome offers human cancer clue - Mar 24, 2011
- High-fat food hastens pancreatic cancer, says study - Jun 21, 2012
- Missing sugar molecule 'increases diabetes risk' - Feb 25, 2011
- Full genetic blueprint of blood cancer offers new insights - Mar 24, 2011
- How a gene mutation leads to autism - Dec 17, 2010
- Red wine, vitamins don't really boost longevity - Jul 07, 2010
- Drug that stops progression of Parkinson's disease in mice found - Mar 09, 2011
- Exposure to low-dose radiation 'ups cancer risk' - Feb 08, 2011
- Potential therapeutic target for schizophrenia identified - Feb 24, 2011
- Scientists successful in creating autism like traits in mice - Mar 22, 2011
- Scientists discover gene linked to clear vision - Dec 20, 2011
Tags: folate, genetic differences, genetic makeup, genetic testing, genetic traits, hemoglobin, kidney damage, mcgill university health, mcgill university health centre, methotrexate, montreal children, mthfr gene, muhc, paving the way, pharmacogenetics, red blood cells, rima, rozen, s hospital, university health centre